147 related articles for article (PubMed ID: 36215425)
1. Acute and Prophylactic Management of Postictal Agitation in Electroconvulsive Therapy.
Sterina E; Gregory N; Hermida AP
J ECT; 2023 Sep; 39(3):136-140. PubMed ID: 36215425
[TBL] [Abstract][Full Text] [Related]
2. Treatment-resistant postictal agitation after electroconvulsive therapy (ECT) controlled with dexmedetomidine.
Bryson EO; Briggs MC; Pasculli RM; Kellner CH
J ECT; 2013 Jun; 29(2):e18. PubMed ID: 23519216
[TBL] [Abstract][Full Text] [Related]
3. Postictal agitation after electroconvulsive therapy: incidence, severity, and propofol as a treatment option.
Tzabazis A; Schmitt HJ; Ihmsen H; Schmidtlein M; Zimmermann R; Wielopolski J; Münster T
J ECT; 2013 Sep; 29(3):189-95. PubMed ID: 23792779
[TBL] [Abstract][Full Text] [Related]
4. Benefits of Dexmedetomidine in Management of Post-ECT Agitation.
Narang P; Ianovich F; Sarai SK; Lippmann S
J ECT; 2017 Sep; 33(3):150-151. PubMed ID: 28178037
[TBL] [Abstract][Full Text] [Related]
5. Use of Orally Disintegrating Olanzapine During Electroconvulsive Therapy for Prevention of Postictal Agitation.
Hermida AP; Janjua AU; Tang Y; Syre SR; Job G; McDonald WM
J Psychiatr Pract; 2016 Nov; 22(6):459-462. PubMed ID: 27824778
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: a case report.
O'Brien EM; Rosenquist PB; Kimball JN; Dunn GN; Smith B; Arias LM
J ECT; 2010 Jun; 26(2):131-3. PubMed ID: 19710618
[TBL] [Abstract][Full Text] [Related]
7. Treatment of post-electroconvulsive therapy agitation with dexmedetomidine.
Cohen MB; Stewart JT
J ECT; 2013 Jun; 29(2):e23-4. PubMed ID: 23519222
[TBL] [Abstract][Full Text] [Related]
8. Preventive effect of dexmedetomidine on postictal delirium after electroconvulsive therapy: A randomised controlled study.
Qiu Z; Zhou S; Zhang M; Guo N; Huang P; Xiang P; Hei Z; Li X
Eur J Anaesthesiol; 2020 Jan; 37(1):5-13. PubMed ID: 31688331
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia.
Aksay SS; Bumb JM; Remennik D; Thiel M; Kranaster L; Sartorius A; Janke C
Neuropsychiatr Dis Treat; 2017; 13():1389-1394. PubMed ID: 28579785
[TBL] [Abstract][Full Text] [Related]
10. Management of severe postictal agitation after electroconvulsive therapy with bispectrum electroencephalogram index monitoring: a case report.
Kranaster L; Janke C; Hoyer C; Sartorius A
J ECT; 2012 Jun; 28(2):e9-10. PubMed ID: 22622306
[TBL] [Abstract][Full Text] [Related]
11. Premedication with dexmedetomidine for prevention of hyperdynamic response after electroconvulsive therapy: a cross-over, randomized controlled trial.
Subsoontorn P; Lekprasert V; Waleeprakhon P; Ittasakul P; Laopuangsak A; Limpoon S
BMC Psychiatry; 2021 Aug; 21(1):408. PubMed ID: 34404384
[TBL] [Abstract][Full Text] [Related]
12. Postanesthesia Recovery Unit Optimization for Patients With Postictal Agitation Secondary to Electroconvulsive Therapy.
Arora V; Tuttle K; Borisovskaya A
J ECT; 2023 Jun; 39(2):91-96. PubMed ID: 36215424
[TBL] [Abstract][Full Text] [Related]
13. Premedication with dexmedetomidine and midazolam attenuates agitation after electroconvulsive therapy.
Mizrak A; Koruk S; Ganidagli S; Bulut M; Oner U
J Anesth; 2009; 23(1):6-10. PubMed ID: 19234815
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological prevention of postictal agitation after electroconvulsive therapy-A systematic review and meta-analysis.
Feenstra TC; Blake Y; Hoogendoorn AW; Koekenbier K; Beekman ATF; Rhebergen D
Front Psychiatry; 2023; 14():1170931. PubMed ID: 37151968
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of ketamine, propofol, and dexmedetomidine for anesthesia in electroconvulsive therapy in treatment-resistant major depressive disorder patients: a double-blind randomized clinical trial.
Modir H; Mahmoodiyeh B; Shayganfard M; Abdus A; Almasi-Hashiani A
Med Gas Res; 2023; 13(3):112-117. PubMed ID: 36571375
[TBL] [Abstract][Full Text] [Related]
16. Propofol for the management of emergence agitation after electroconvulsive therapy: review of a case series.
O'Reardon JP; Takieddine N; Datto CJ; Augoustides JG
J ECT; 2006 Dec; 22(4):247-52. PubMed ID: 17143155
[TBL] [Abstract][Full Text] [Related]
17. Safety of dexmedetomidine for the control of agitation in critically ill traumatic brain injury patients: a descriptive study.
Bilodeau V; Saavedra-Mitjans M; Frenette AJ; Burry L; Albert M; Bernard F; Williamson DR
J Clin Pharm Ther; 2021 Aug; 46(4):1020-1026. PubMed ID: 33606290
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine Combined With Intravenous Anesthetics in Electroconvulsive Therapy: A Meta-analysis and Systematic Review.
Li X; Tan F; Cheng N; Guo N; Zhong ZY; Hei ZQ; Zhu QQ; Zhou SL
J ECT; 2017 Sep; 33(3):152-159. PubMed ID: 28263242
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Postictal Agitation After Electroconvulsive Therapy.
Allen ND; Allison CL; Golebiowski R; Janowski JPB; LeMahieu AM; Geske JR; Rasmussen KG
J ECT; 2022 Mar; 38(1):60-61. PubMed ID: 34739422
[TBL] [Abstract][Full Text] [Related]
20. Use of dexmedetomidine in treatment-refractory post-electroconvulsive therapy agitation.
Brydges D; Tibrewal P; Waite S; Dhillon R
Aust N Z J Psychiatry; 2016 Apr; 50(4):386-7. PubMed ID: 26508796
[No Abstract] [Full Text] [Related]
[Next] [New Search]
